2.06 USD
+0.05 (+2.49%)
1.95 USD
-0.11 (-5.34%)
ChartMill assigns a Buy % Consensus number of 82% to AYTU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.35. This target is 353.89% above the current price.
AYTU was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AYTU.
In the previous month the buy percentage consensus was at a similar level.
AYTU was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-25 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-25 | Maxim Group | Maintains | Buy -> Buy |
| 2025-07-01 | Lake Street | Initiate | Buy |
| 2025-06-30 | Ascendiant Capital | Initiate | Buy |
| 2023-08-09 | Maxim Group | Initiate | Buy |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-07-21 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-04-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-30 | Cantor Fitzgerald | Initiate | Overweight |
AYTU BIOPHARMA INC / AYTU FAQ
Can you provide the average price target for AYTU BIOPHARMA INC stock?
9 analysts have analysed AYTU and the average price target is 9.35 USD. This implies a price increase of 353.88% is expected in the next year compared to the current price of 2.06.
What is the consensus rating for AYTU stock?
The consensus rating for AYTU BIOPHARMA INC (AYTU) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed AYTU BIOPHARMA INC (AYTU)?
The number of analysts covering AYTU BIOPHARMA INC (AYTU) is 9.